4D Pharma | Sustainability Performance
Focuses on researching and developing live biotherapeutic products by analyzing the human microbiome. Engages in both preclinical and clinical-stage programs across various therapeutic areas, aiming to explore microbial interactions with human health through proprietary scientific platforms and collaborations.
2014
United Kingdom
51 - 200 employees
Pharmaceuticals
$500K - 1M in revenue
Sustainability Ranking & Industry Benchmark
#11364
Overall#1372
in United Kingdom#261
in PharmaceuticalsSustainability Maturity
Sustainability Intent
Overview
Governance
TargetsESG scores and ExclusionsFinancial Data
Business performanceCapital & innovationAnalyst projections
Revenue
Controversy level
Powered by illuminem
Revenue
EBITDA
Operating margin
Revenue & EBITDA
$0.0FY2019 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
Return on invested capital
-163.0%FY2026
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
0.0
2024Powered by illuminem
Environmental policy coverage
Carbon reduction policy
Not available
Human rights policy
Not available
Recycling policy
Not available
Workplace health & safety policy
Not available
63%
Independent Directors
5 out of 8 incl. management
Overall score
0
Environment
0
Social
0
Governance
0
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Not available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
